|
US4115577A
(en)
*
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4013652A
(en)
*
|
1972-06-19 |
1977-03-22 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzoxazine
|
|
US4183936A
(en)
*
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
ES481298A1
(es)
*
|
1978-06-05 |
1980-08-16 |
Sankyo Co |
Un procedimiento para preparar nuevos benzotiazo-derivados.
|
|
US4219550A
(en)
*
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
|
EP0357417A1
(fr)
*
|
1988-09-01 |
1990-03-07 |
Glaxo Group Limited |
Dérivés de lactames
|
|
US5223625A
(en)
*
|
1988-12-22 |
1993-06-29 |
Duphar International Research B.V. |
Annelated indolo [3,2,-C]lactams
|
|
EP0380155A1
(fr)
*
|
1989-01-19 |
1990-08-01 |
Duphar International Research B.V |
Dérivés de 1,2,3,4-tétrahydro-bêta-carboline, 8,9-annelés
|
|
MXPA01012914A
(es)
|
1999-06-15 |
2004-04-21 |
Bristol Myers Squibb Co |
Gama-carbolinas fundidas de heterociclo substituido.
|
|
US7071186B2
(en)
*
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
EP1399445B9
(fr)
|
2000-12-20 |
2010-07-21 |
Bristol-Myers Squibb Company |
Pyrroloquinoleines et pyridoquinoleines substituees comme agonistes et antagonistes de la serotonine
|
|
MXPA03005438A
(es)
*
|
2000-12-20 |
2004-05-05 |
Bristol Myers Squibb Co |
Pirioindoles substituidos como agonistas y antagonistas de serotonina.
|
|
US6849619B2
(en)
*
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
BR0116347A
(pt)
|
2000-12-20 |
2004-07-06 |
Bristol Myers Squibb Pharma Co |
Derivados pirazinoquinoxalina substituìdos como agonistas e antagonistas do receptor de serotonina
|
|
US6887868B2
(en)
|
2001-09-21 |
2005-05-03 |
Pharmacia & Upjohn Company |
Therapeutic 5-HT ligand compounds
|
|
AU2003303210A1
(en)
*
|
2002-12-19 |
2004-07-14 |
Bristol-Myers Squibb Company |
Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
|
|
CN101796051B
(zh)
*
|
2007-03-12 |
2013-11-06 |
细胞内治疗公司 |
与取代的杂环稠合的γ-咔啉的合成
|
|
US8575186B2
(en)
|
2009-10-05 |
2013-11-05 |
Albany Molecular Research, Inc. |
Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
|
|
CA2823955A1
(fr)
|
2011-01-19 |
2012-07-26 |
Albany Molecular Research, Inc. |
Benzofuro[3,2-c]pyridines et analogues associes en tant que modulateurs du sous-type 6 de la serotonine (5-ht6) pour traitement de l'obesite, du syndrome metabolique, de la cognition et de la schizophrenie
|
|
EP2836211B1
(fr)
|
2012-04-14 |
2019-03-20 |
Intra-Cellular Therapies, Inc. |
Traitement du PTSD et du trouble des impulsions
|
|
PT2968320T
(pt)
|
2013-03-15 |
2021-01-28 |
Intra Cellular Therapies Inc |
Compostos orgânicos
|
|
IL321987A
(en)
*
|
2013-12-03 |
2025-09-01 |
Intra Cellular Therapies Inc |
A long-acting injectable preparation containing polymeric microspheres of modified compressed gamma-carboline heterocyclic compounds or a sustained-release pharmaceutical preparation containing these compounds for use in the treatment of bipolar I and/or bipolar II disorders
|
|
CN106456638A
(zh)
|
2014-04-04 |
2017-02-22 |
细胞内治疗公司 |
有机化合物
|
|
WO2015154025A1
(fr)
|
2014-04-04 |
2015-10-08 |
Intra-Cellular Therapies, Inc. |
Composés organiques
|
|
CA3011983A1
(fr)
|
2016-01-26 |
2017-08-03 |
Intra-Cellular Therapies, Inc. |
Gamma-carbolines fusionnees a heterocycles substituees
|
|
EP3407889B1
(fr)
|
2016-03-25 |
2021-05-19 |
Intra-Cellular Therapies, Inc. |
Composés organiques et leur utilisation dans le traitement ou la prévention de maladies du système nerveux central
|
|
US10682354B2
(en)
|
2016-03-28 |
2020-06-16 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
JP2019513143A
(ja)
|
2016-03-28 |
2019-05-23 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規塩類および結晶
|
|
JP6997718B2
(ja)
|
2016-03-28 |
2022-01-18 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
新規共結晶
|
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
|
WO2018126140A1
(fr)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Composés organiques
|
|
WO2018126143A1
(fr)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Composés organiques
|
|
WO2018175969A1
(fr)
|
2017-03-24 |
2018-09-27 |
Intra-Cellular Therapies, Inc. |
Nouvelles compositions et méthodes
|
|
IL272252B2
(en)
|
2017-07-26 |
2024-03-01 |
Intra Cellular Therapies Inc |
Derivatives of substituted heterocycle fused gamma-carbolines, pharmaceutical compositions comnprising them and their use in treatment
|
|
KR102899502B1
(ko)
|
2017-07-26 |
2025-12-11 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
MX2020009928A
(es)
|
2018-03-23 |
2021-01-08 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
|
EP3628007B1
(fr)
|
2018-06-06 |
2023-05-03 |
Intra-Cellular Therapies, Inc. |
Nouveaux sels et cristaux
|
|
WO2019237037A1
(fr)
|
2018-06-08 |
2019-12-12 |
Intra-Cellular Therapies, Inc. |
Nouvelles méthodes
|
|
EP3609891B1
(fr)
|
2018-06-11 |
2026-02-11 |
Intra-Cellular Therapies, Inc. |
Synthèse de gamma-carbolines fusionnées à hétérocycles substitués
|
|
WO2020047241A1
(fr)
|
2018-08-29 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Nouvelles compositions et méthodes
|
|
KR20210052472A
(ko)
|
2018-08-31 |
2021-05-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
|
WO2020047407A1
(fr)
|
2018-08-31 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Nouvelles méthodes
|
|
BR112022000231A2
(pt)
|
2019-07-07 |
2022-02-22 |
Intra Cellular Therapies Inc |
Novos métodos
|
|
US12414948B2
(en)
|
2022-05-18 |
2025-09-16 |
Intra-Cellular Therapies, Inc. |
Methods
|